Description

The global medical device market is expected to grow USD 630.3 billion in 2027 from USD 436.2 billion in 2020 and register a CAGR of 5.4% from 2021 to 2027. The medical device industry is being transformed by technological advancements, expanding the number of connected medical devices accessible on the market while also enhancing their role in healthcare. The scenario of device connectivity is evolving due to advancements in wireless technologies, smaller devices, and computer power. Medical device data is being gathered, analyzed, and shared with healthcare organizations, resulting in better patient outcomes, lower costs, and an extra income opportunity. Integrating and presenting patient data correctly can only assist MedTech thrive in the future.

Depending on the device, market dynamics for pricing medical devices might be rather variable. Conventional surgical equipment, such as surgical gloves and other common surgical supplies, has a competitive market. These products are regarded as interchangeable goods. Companies compete intensely on pricing, and to be successful; they frequently require huge sales volumes. In contrast, markets for advanced items like implantable medical devices, like their pharmaceutical equivalent, are protected in mystery. Advanced device markets are more difficult to get and less competitive, enabling device manufacturers to demand higher costs and make significant profits. 

Changing government regulations and policies for the manufacturing of medical devices are all elements in the political sphere that could impact the medical devices market. A change in regulations may call for higher spending on devices. The government at the global level is focusing on more budgets, boosting growth in the long term. Medical device regulation in the EU is governed by three EU council directives 90/385/EEC on active implantable medical devices, 93/42/EEC on medical devices, and 98/79/EC on in vitro diagnostic medical devices.

COVID-19 Impact on the Global Medical Device Market

The global economy was devastated by the epidemic. Because of the lockdown and stringent controls implemented by governments during pandemics to stop the virus from spreading, manufacturing facilities witnessed a drop in output capacity. The FDA announced that it would suspend normal inspections of food, drugs, and medical devices in other countries, citing the virus's global spread. Global sourcing of high-tech products, such as respiratory ventilators and related equipment, has turned into a race. In 2019, the US imported $22 billion of high-tech medical equipment, such as CT scanners, ultrasound machines, patient monitors, and X-ray machines, to diagnose and treat patients. The effects of COVID-19 and related actions to control its spread have negatively impacted certain market players' businesses, beginning in the last few weeks of March 2020. For instance, Johnson & Johnson Services, Inc. reported revenue of USD 23.0 billion in 2020, a decrease of 11% from 2019. Another serious medical device manufacturer, Medtronic, had a 5.4 % drop in sales in the fiscal year 2020 and a substantial 26 % drop in the fourth quarter of 2020, compared to 2019. On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic, and governments worldwide mandated orders to slow the transmission of the virus. Many jurisdictions declared states of emergency, and countries worldwide took steps to restrict travel, instituted work from home policies, enacted temporary closures of businesses, issued quarantine orders, and took other restrictive measures in response to the COVID-19 pandemic. Uncertainty concerning the economic effects of the pandemic and the restrictive policies to mitigate its spread have introduced significant volatility in the medical devices markets. Certain markets have reopened while others remain closed or have closed again to control the spread of the virus.

Global Medical Device Market Dynamics

Drivers: Surging incidence of chronic diseases

Adopting sedentary lifestyles and irregularity in routine healthcare checkups in emerging and developed countries increases lifestyle-related chronic diseases such as obesity, neuro-based diseases, heart disease, diabetes, and many more. For instance, according to the American Heart Association, the number of deaths due to cardiovascular diseases was 17.6 million in 2016 and is projected to rise to over 23.6 million by 2030. Also, as per Global Health Data Exchange, the number of neurological disorder cases registered in Singapore was 2,065,419.9 in 2017 and has risen to 2,075,898.7 in 2019. Such a rise in chronic disease worldwide is driving the demand for the medical device market in the forecasting period.

Moreover, the surging prevalence of cancer across the globe influence a positive outlook for the growth of the market. Early diagnosis of cancer can lead to better treatment and a greater lifespan. Some cancer prevention screening tests include different medical imaging tests, screening mammography, and more, thereby augmenting the growth of medical devices across the globe. For instance, as per Global Health Data Exchange, the total number of leukemia cases globally was around 323,913.03 in 2017 and rose to 334,592.26 in 2019. Thus, the increase in the prevalence of cancer across the globe will foster medical device market growth.

Restraints: High cost of medical devices to restrict the market growth

In the last decade, the medical device industry has seen significant changes in new technology and design, among other factors. However, the high cost of these devices, including a higher acquisition cost and subsequent maintenance cost, leads to a higher overall device cost of ownership. Some modern medical devices include additional parts, such as chips, batteries, sensors, and other accessories, that must be replaced regularly. For instance, in the United States, an insulin pump costs between USD 4,500 and USD 6,500 per device. Furthermore, the entire annual cost of medical device accessories, including batteries, syringes, and other products, is about USD 1500. As a result, the patient's total cost of ownership is greater. Thus, the availability of higher-cost medical devices products in the market is restraining the market growth.

Opportunities: Technological Advancements to Bolster the Medical Devices Industry

The medical device industry has been significantly transformed by 3D printing in the healthcare industry. It enables the development of customized devices for patients since it allows easy design modifications without extra equipment, likely to boost the market growth. Furthermore, it employs a range of technologies to quickly construct complex structures, increasing the production of advanced medical devices. This makes them important for orthopedic implant applications as it allows for the production of long-lasting, high-quality, and optimal-fit implants with improved performance and flexibility.

Furthermore, the use of 3D printing in manufacturing can assist in the development of improved and high-performance surgical instruments like hemostats and forceps, which is likely to drive market growth. Medical devices are benefiting from the strong growth of the medical technology industry. The market is projected to increase as new technologies, such as artificial intelligence (AI), are integrated to improve diagnosis. Furthermore, artificial intelligence (AI) assists healthcare professionals in remotely monitoring patients via sensors and automating therapy administration through mobile apps.

Scope of the Report

The study categorizes the medical device market based on category, application, sector, end-user, and application at the regional and global levels.

By Category Outlook (Sales, USD Million, 2017-2027)

• Diagnostic Devices
  1. Electrodiagnostic Devices
  2. Radiation Devices
  3. Imaging Parts & Accessories
• Consumables
  1. Syringes, Needles & Catheters
  2. Bandages & Dressings
  3. Suturing Materials
  4. Other Consumables
• Patient Aids
  1. Portable Aids
  2. Therapeutic Applications
• Orthopaedics and Prosthetics
  1. Fixation Devices
  2. Artificial Joints
  3. Other Artificial Body Parts
• Dental Products
  1. Dental Instrument & Supplies
  2. Dental Capital Equipment
• Patient Monitoring Devices
• MIS
• IVD
• Other Medical Device Categories

By Application Outlook (Sales, USD Million, 2017-2027)

• Diagnostic Imaging Devices
• In Vitro Diagnostics (IVDs)
• Cardiology
• Orthopedics
• Ophthalmics
• Respiratory
• Urology & Gynecology
• General and Plastic Surgery
• Endoscopy
• Dental
• Diabetic Care
• Wound Management
• Nephrology
• General Hospital and Healthcare
• Ear, Nose, and Throat
• Neurology
• Robotics Navigation
• Other Applications

By Sector (Sales, USD Million, 2017-2027)

• Public 
• Private

By End-Users (Sales, USD Million, 2017-2027)

• Hospitals & Surgical Centers
• Clinics
• Household
• Other End-Users

By Region Outlook (Sales, USD Million, 2017-2027)

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

The cardiology segment is projected to account for the largest market share, by category

Based on category, the global medical device market has been segmented into Diagnostic Imaging Devices, In Vitro Diagnostics (IVDs), Cardiology, Orthopedics, Ophthalmic, Respiratory, Urology & Gynecology, General and Plastic Surgery, Endoscopy, Dental, Diabetic Care, Wound Management, Nephrology, General Hospital and Healthcare, Ear, Nose and Throat, Neurology, Robotics Navigation, and Other Applications. The cardiology segment in the medical devices market holds the largest share of 18.9% in 2020. 

The major factors driving the growth of the cardiology devices segment are the rising global prevalence of coronary heart diseases, such as stroke and cardiomyopathy, which cause a global burden of cardiac deaths. According to the article, ‘Prevalence of Cardiovascular Disease in Adults,’ published in February 2020 in the US Pharmacist, in 2018, 30.3 million adults (12.1%) in the United States were diagnosed with cardiovascular diseases.

Asia Pacific accounts for the highest CAGR during the forecast period 

The global medical device market has segmented as North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. Globally, Asia Pacific is estimated to hold the highest CAGR of 7.1% in the global medical device market during the forecast period. The region includes the countries such as China, India, Japan, South Korea, Australia, Southeast Asia, and the Rest of Asia-Pacific. The region's growth is primarily due to strong economic growth in the domestic emerging countries such as China, Indonesia, Malaysia, and India.

In the Asia Pacific, China holds 54.5% of the market revenue share in 2020. Whereas India is the fastest-growing region with a CAGR of 8.3% during the forecast period. Based on the Application, the cardiology segment contributed 18.6% in the Asia-Pacific medical devices market. The cardiology segment was valued at USD 22.6 billion in 2020, expected to reach USD 39.0 billion by 2027. The respiratory application in Asia-pacific is growing at the fastest CAGR of 8.6% during the forecast period.

Key Market Players

The medical device market is mildly concentrated in nature, with few numbers of global players operating in the market such as 3M, Abbott Laboratories, Allergan Inc., Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cryolife Inc., Danaher Corporation, Endologix LLC, EssilorLuxottica SA, Fresenius Medical Care, GE Healthcare, Johnson & Johnson, Koninklijke Philips, Medtronic PLC, Roche Diagnostics, Olympus, Siemens AG, Smith & Nephew Plc., Stryker Corp., Terumo Medical Corporation, Thermo Fisher Scientific., Zimmer Biomet.

Recent Developments

• In November 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S. The device is the smallest and lightest portable handheld nebulizer.
• In June 2021, Medtronic PLC launched The SonarMed airway monitoring system for newborns. It assisted in identifying or addressing serious risks to newborns treated with mechanical ventilators and breathing tubes.
• In September 2021, Olympus Corporation announced the launch of the first devices in the new POWERSEALTM family of advanced bipolar surgical energy products. The POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-Action devices meet the highest clinical performance standards for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.
• In May 2020, Roche acquired Stratos Genomics, an early-stage sequencing technology company, to advance the development of Roche’s nanopore sequencer. The acquisition provided Roche with Stratos Genomics' unique chemistry, Sequencing by Expansion (SBX). The Roche nanopore sequencer, once developed, will utilize a novel approach that combines electronic and biological components to sequence DNA for fast, flexible, and cost-effective clinical diagnostic testing.

Key Issues Addressed

• What is the market size by various segmentation of the medical device by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's five forces of the medical device market?
• What are the key opportunities and trends for manufacturers involved in the medical device supply chain?
• What are the market's fundamental dynamics (drivers, restraints, opportunities, and challenges)?
• What and how are regulations, schemes, patents, and policies impacting the market's growth?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the global market's demand and sales of medical devices? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.